Bipolar disorder is a condition characterized by cyclical mood swings, transitioning from depression to mania (or hypomania). For a period of time, an individual with bipolar disorder will experience debilitating bouts of depression – and often unexpectedly, their entire neurophysiology will shift to facilitate a state of mania (elevated mood). Diagnostically, there are multiple types …
Latuda (Lurasidone) is a relatively new atypical antipsychotic that was approved in 2013 for the treatment of schizophrenia and depressive episodes in Type 1 Bipolar disorder. Many have made the argument that since this is a “newer” antipsychotic, it’s likely to be “better” than the crop of older medications on the market. While no single …
Latuda (Lurasidone) is a new atypical antipsychotic drug that is approved for the treatment of depressive episodes in bipolar disorder (type 1) as well as schizophrenia. It is considered a relatively new drug as it was just approved in 2013 to treat depressive episodes for people with bipolar I disorder. This drug is somewhat unique …